13F filing recap · Q4 2016

What did Fairfax Financial Holdings buy in Q4 2016?

Reported stock-position changes between this filing and the previous one.

Stock value

$1.17B

Positions

Estimated turnover

11.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

MONMonsanto Company$653.0Kreported value+6.2K shares VALValspar Corporation$643.0Kreported value+6.2K shares DESTDestination Maternity Corp$360.0Kreported value+70.0K shares TMHTeam Health Holdings Inc$260.0Kreported value+6.0K shares

Increased positions

KWKennedy-Wilson Holdings Inc$251.98Mreported value+3.37M shares+37.6%XCOExco Resources Inc$24.06Mreported value+2.00M shares+7.8%USBUS Bancorp$20.96Mreported value+384.8K shares+1658.6%JNJJohnson & Johnson$17.43Mreported value+68.4K shares

Reduced positions

IBMInternational Business Machines Corp$226.06Mreported value-600 shares-0.0%BWINBBaldwin & Lyons Inc (now the Baldwin Insurance Group Inc)$9.51Mreported value-592.4K shares-61.1%WFCWells Fargo & Company/mn$3.63Mreported value-3.5K shares-5.1%BRK.BBerkshire Hathaway Inc$2.61Mreported value

Exited positions

LXKLexmark International Inc$647.0Kprior reported value-16.2K shares-100.0%VAVirgin America Inc$589.0Kprior reported value-11.0K shares-100.0%CVTCvent Inc$460.0Kprior reported value-14.5K shares-100.0%CSXCsx Corporation$299.0Kprior reported value-9.8K shares